Published in J Nephropathol on April 05, 2012
Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci (2012) 2.66
Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study. Int J Prev Med (2013) 1.90
Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study. J Nephropathol (2012) 1.82
Preventive and curative effects of ginger extract against histopathologic changes of gentamicin-induced tubular toxicity in rats. Int J Prev Med (2013) 1.32
Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients. Int J Prev Med (2013) 0.98
Significance of extracapillary proliferation in IgA-nephropathy patients with regard to clinical and histopathological variables. Hippokratia (2013) 0.93
A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J Res Med Sci (2013) 0.84
What is the Real Fate of Vitamin D in Multiple Sclerosis? Int J Prev Med (2013) 0.84
Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital. Int J Prev Med (2013) 0.84
Comparative evaluation of three different methods for HbA1c measurement with High-performance liquid chromatography in diabetic patients. Adv Biomed Res (2014) 0.84
Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics. Int J Prev Med (2013) 0.78
Predictive factors of neurological complications and one-month mortality after liver transplantation. Front Neurol (2014) 0.77
Non-monetary renal transplantation: An old issue and a new look from Holy Quran. J Nephropathol (2012) 0.75
Association of helicobacter pylori infection with serum magnesium in kidney transplant patients. J Renal Inj Prev (2014) 0.75
The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol (1996) 2.77
Patterns of graft rejection following liver transplantation. J Hepatol (1990) 2.11
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review. Ann Intern Med (2011) 1.81
Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells. Eur J Immunol (2011) 1.49
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs (1993) 1.25
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology (1998) 1.16
Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation. Ann Transplant (2011) 1.08
T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. J Immunol (1993) 1.08
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol (2010) 1.04
Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. Mayo Clin Proc (1993) 0.99
Cyclosporine in transplantation - a history of converging timelines. J Biol Regul Homeost Agents (2012) 0.96
A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation. J Clin Pharmacol (2011) 0.93
A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) (2012) 0.91
The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus. Ther Drug Monit (2012) 0.88
Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol (2012) 0.86
In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. Clin Chem Lab Med (2000) 0.85
Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs R D (2004) 0.85
Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 2. Structural modifications of the spermidine moiety. J Med Chem (1999) 0.84
Kidney transplant recipients and the incidence of adverse reactions to cyclosporin. Saudi Med J (2004) 0.83
The history and development of organ transplantation: biology and rejection. Baillieres Clin Gastroenterol (1994) 0.83
Changes in T lymphocyte subsets and intracellular cytokines after transfer of chemically extracted acellular nerve allografts. Mol Med Rep (2012) 0.83
New insights into mechanisms of allograft rejection. Am J Med Sci (1997) 0.83
Soluble interleukin 2-receptor alpha secretion is related to altered interleukin 2 production in thermally injured patients. Burns (1991) 0.82
Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model. Am J Transplant (2012) 0.82
Significance of T helper 17 immunity in transplantation. Curr Opin Organ Transplant (2012) 0.82
France and the early history of organ transplantation. Perspect Biol Med (1993) 0.82
Management of the liver transplant patient. Expert Rev Gastroenterol Hepatol (2009) 0.81
Mechanisms and management of acute renal allograft rejection. Surg Clin North Am (1998) 0.81
Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis. Eur J Clin Pharmacol (1991) 0.81
Class II MHC self-antigen presentation in human B and T lymphocytes. PLoS One (2012) 0.81
Impact of new immunosuppressive agents on late graft outcome. Kidney Int Suppl (1997) 0.80
The evolution of therapeutic immunosuppression and the potential impact of drug concentration monitoring. Ther Drug Monit (1995) 0.80
Graft rejection - endogenous or allogeneic? Immunology (2012) 0.80
Major histocompatibility complex allele-specific peptide libraries and identification of T-cell mimotopes. Methods Mol Biol (1998) 0.79
[Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression]. Medicina (B Aires) (2012) 0.79
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients. Saudi J Kidney Dis Transpl (2010) 0.79
New immunosuppressive agents. Gastroenterol Clin North Am (1993) 0.78
Liver transplantation. Gastroenterology (1997) 0.78
[Rejection of a liver allograft. Diagnosis and treatment]. Ann Radiol (Paris) (1994) 0.78
State of the art of liver transplantation in the USA. Transplant Proc (1993) 0.78
Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats. Transplant Proc (1989) 0.78
Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. Transplantation (1995) 0.77
Immunologic mechanism of rejection and graft-versus-host disease following orthotopic small intestinal transplantation in rats. Transplant Proc (1998) 0.77